Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 1/20 | 0.60 |
| ▸ | HCAR2 | Q8TDS4 | 5/20 | 0.55 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 6/20 | 0.40 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | NAAA | Q02083 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20875236 | 1.00 | ATM (0.60) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL25174772 | 0.98 | ATM (0.64) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL28872434 | 0.98 | ATM (0.58) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL20875241 | 0.98 | ATM (0.58) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL20913247 | 0.95 | ATM (0.60) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL20394541 | 0.93 | ATM (0.64) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL1068258 | 0.91 | ATM (0.69) | ATMHCAR2TSHRHPGDMAPT | |
| SCHEMBL9627582 | 0.91 | ATM (0.52) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL19548600 | 0.91 | ATM (0.52) | ATMHCAR2TSHRALDH1A1CYP3A4 | |
| SCHEMBL573684 | 0.91 | ATM (0.52) | ATMHCAR2TSHRALDH1A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4743828-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2026-05-20 | — | — | EP | disclosed |
| WO-2025011754-A1 | PHOTOCURABLE AS WELL AS THERMALLY CURABLE COMPOSITIONS SUITABLE FOR LOW TEMPERATURE CURING | BASF SE (DE) | 2025-01-16 | — | — | WO | disclosed |
| EP-4114825-B1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2024-11-20 | — | — | EP | disclosed |
| EP-3392292-B1 | METHOD FOR PRODUCING HETEROCYCLE-CONTAINING POLYMER PRECURSOR, HETEROCYCLE-CONTAINING POLYMER PRECURSOR, AND USE FOR SAME | FUJIFILM CORP (JP) | 2023-06-28 | — | — | EP | disclosed |
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-05-11 | — | — | US | disclosed |
| CN-109313397-B | Method for manufacturing laminate, method for manufacturing semiconductor element, and laminate | 富士胶片株式会社 | 2023-04-11 | — | — | CN | disclosed |
| US-11597230-B2 | Volume hologram sheet to be embedded, forgery prevention paper, and card | DAI NIPPON PRINTING CO., LTD. (JP) | 2023-03-07 | — | — | US | disclosed |
| EP-4114825-A1 | OXIME ESTER PHOTOINITIATORS | BASF SE (DE) | 2023-01-11 | — | — | EP | disclosed |
| CN-115210219-A | Oxime ester photoinitiators | 巴斯夫欧洲公司 | 2022-10-18 | — | — | CN | disclosed |
| EP-3162868-B1 | THERMAL BASE GENERATOR, THERMOSETTING RESIN COMPOSITION, CURED FILM, CURED FILM MANUFACTURING METHOD, AND SEMICONDUCTOR DEVICE | FUJIFILM CORP (JP) | 2022-10-05 | — | — | EP | disclosed |
| CN-108700836-B | Method for manufacturing laminate and method for manufacturing semiconductor device | 富士胶片株式会社 | 2022-06-28 | — | — | CN | disclosed |
| US-20220121113-A1 | OXIME ESTER PHOTOINITIATORS HAVING A SPECIAL AROYL CHROMOPHORE | BASF SE (DE) | 2022-04-21 | — | — | US | disclosed |
| EP-0734309-B1 | ABRASIVE ARTICLE | MINNESOTA MINING & MFG (US) | 1998-12-09 | — | — | EP | disclosed |
| EP-0734309-A1 | ABRASIVE ARTICLE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1996-10-02 | — | — | EP | disclosed |
| WO-1995016547-A1 | ABRASIVE ARTICLE | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-06-22 | — | — | WO | disclosed |
| US-5391210-A | With cured ceramer composite binder | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1995-02-21 | — | — | US | disclosed |
| EP-0332043-B1 | Oxadiazole derivatives containing 4,6-bis-trichloromethyl-s-triazin-2-yl groups, process for their preparation and photosensitive mixture containing them | HOECHST AG (DE) | 1994-05-18 | — | — | EP | disclosed |
| EP-0332044-B1 | HETEROCYCLIC COMPOUNDS CONTAINING 4,6-BIS-TRICHLOROMETHYL-S-TRIAZIN-2-YL GROUPS, PROCESS FOR THEIR PREPARATION AND PHOTOSENSITIVE MIXTURE CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1993-06-16 | — | — | EP | disclosed |
| EP-0332043-A1 | Oxadiazole derivatives containing 4,6-bis-trichloromethyl-s-triazin-2-yl groups, process for their preparation and photosensitive mixture containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-09-13 | — | — | EP | disclosed |
| EP-0332044-A1 | Heterocyclic compounds containing 4,6-bis-trichloromethyl-s-triazin-2-yl groups, process for their preparation and photosensitive mixture containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1989-09-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230142648-A1 | OXIME ESTER PHOTOINITIATORS | OCIAD1, OCIAD2, OXER1 | ATM 1370/4885HCAR2 1233/4885TSHR 2202/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.